144 related articles for article (PubMed ID: 26002815)
21. Cardiac scintigraphy with
de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
[TBL] [Abstract][Full Text] [Related]
22. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
23. Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis.
Lin H; Zhang X; Einstein AJ; Tang G
J Nucl Cardiol; 2022 Aug; 29(4):2024-2028. PubMed ID: 35655112
[No Abstract] [Full Text] [Related]
24. Performance of
Awaya T; Minamimoto R; Iwama K; Kubota S; Hotta M; Hirai R; Yamamoto M; Okazaki O; Hara H; Hiroi Y; Hiroe M; Moroi M
J Nucl Cardiol; 2020 Aug; 27(4):1145-1153. PubMed ID: 31591695
[TBL] [Abstract][Full Text] [Related]
25. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
26. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
27. Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D.
Yamashita T; Ueda M; Saga N; Nanto K; Tasaki M; Masuda T; Misumi Y; Oda S; Fujimoto A; Amano T; Takamatsu K; Yamashita S; Obayashi K; Matsui H; Ando Y
Amyloid; 2016 Sep; 23(3):207-208. PubMed ID: 27646980
[No Abstract] [Full Text] [Related]
28. Serial scanning with technetium pyrophosphate (
Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Amyloid Cardiomyopathy Diagnosed on Incidental Myocardial Uptake During Bone Scintigraphy.
Ikebe S; Takashio S; Nishi M; Morioka M; Tsujita K
Circ J; 2020 Mar; 84(4):679. PubMed ID: 32132309
[No Abstract] [Full Text] [Related]
30. Alternative Isotope Options for Amyloidosis Imaging: A Technologist's Perspective.
Warren J
J Nucl Med Technol; 2023 Jun; 51(2):117-119. PubMed ID: 37192821
[TBL] [Abstract][Full Text] [Related]
31. Uptake of technetium 99m HDP in cardiac amyloidosis.
Kulhanek J; Movahed A
Int J Cardiovasc Imaging; 2003 Jun; 19(3):225-7. PubMed ID: 12834159
[TBL] [Abstract][Full Text] [Related]
32. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
33. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
34. Pattern of myocardial
Pradel S; Brun S; Victor G; Pascal P; Fournier P; Ribes D; Lavie-Badie Y; Galinier M; Carrié D; Berry I; Lairez O;
J Nucl Cardiol; 2020 Feb; 27(1):96-105. PubMed ID: 29881913
[TBL] [Abstract][Full Text] [Related]
35. Extracardiac soft tissue uptake, evidenced on early
Malka N; Abulizi M; Kharoubi M; Oghina S; Galat A; Le Bras F; Moktefi A; Guendouz S; Molinier-Frenkel V; Fanen P; Funalot B; Lefaucheur JP; Blanc-Durand P; Deux JF; Audard V; Bodez D; Itti E; Damy T
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2396-2406. PubMed ID: 32157431
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
[No Abstract] [Full Text] [Related]
37. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
Cuscaden C; Ramsay SC; Prasad S; Goodwin B; Smith J
J Nucl Cardiol; 2021 Dec; 28(6):2845-2856. PubMed ID: 32385832
[TBL] [Abstract][Full Text] [Related]
38. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
[TBL] [Abstract][Full Text] [Related]
39. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
40. Tc-99m HDP uptake in cardiac amyloidosis.
Wadhwa SS; Nour R
Clin Nucl Med; 1999 Mar; 24(3):156-8. PubMed ID: 10069722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
